Zantac and other ranitidine medications have received a lot of press lately. In April of 2020, the Federal Drug Administration (FDA) withdrew all Zantac and generic equivalents from the market due to detection of the dangerous contaminate NDMA (N-Nitrosodimethylamine). One of the negative effects associated with NDMA is kidney cancer.
NDMA is considered a probable carcinogen by a variety of noted national and international health organizations, which means that it probably causes cancer. One of the cancers associated with NDMA is kidney cancer.
The connection between Zantac and NDMA was initially identified by an online drugstore that – in its commitment to consumer safety – found NDMA in the popular heartburn and GERD medication, Zantac (and other ranitidine products) in the spring of 2019. Since this discovery, some pharmaceutical companies initiated recalls of the medications, and many large drugstore chains pulled the drugs from their shelves. The FDA took several more months before it implemented its market withdrawal of Zantac and its generics.
Kidney cancer begins in the kidneys, and according to the Mayo Clinic, it is often asymptomatic in the early stages, which makes it more difficult to detect and, consequently, more difficult to adequately treat. The symptoms associated with kidney cancer in the later stages include:
If you used Zantac regularly and now have Kidney cancer, you need a dedicated drug injury attorney on your side.
2 years ago I was involved in a trucking accident involving a 14-wheeler truck that nearly disabled me for life. Steve fought to make sure that I received the most possible compensation for my injuries. I was about to take the insurance company’s lowball offer, but decided to call Steve first – it was the best decision I’ve made yet
NOAH TAFFELPersonal Injury Victim